TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment
F. Azar et al. Journal for ImmunoTherapy of Cancer July 2024 Download the publication here Publication